AzTrials
AzTrials

AppetiteNCT07600281

Ultra-Processed Foods, Palatability, Appetite, and Gastrointestinal Transit

A study testing Palatable Ultra-Processed Food Meal, Unpalatable Ultra-Processed Food Meal and Palatable Non-Ultra-Processed Food Meal in people with Appetite and Gastrointestinal Transit, run by Purdue University at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The goal of this clinical trial is to learn how food processing level affects appetite and gastrointestinal transit time when meal palatability is changed. Participants will complete one screening visit and four test visits. Read more about this study

Who is it for?
Ages 18 to 60 yearsHealthy volunteers can take part
What is being tested?
Palatable Ultra-Processed Food Meal, Unpalatable Ultra-Processed Food Meal and Palatable Non-Ultra-Processed Food Meal
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
1 siteUnited States
Study dates
24 Sep 2024to 30 Apr 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 60 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Individuals aged 18 to 60 years.
  • Any sex, gender, or orientation.
  • Self-reported good health.
  • No medication use.
  • No allergies or food sensitivities to any of the foods used in the study.
  • No anticipated change in physical activity during the study period.
Show all 9Show fewer
  • Willingness to complete all planned study activities, including the screening visit and four test visits.
  • At screening, participants must rate the selected high-palatability foods between 60 and 90 on a 100-unit visual analog scale, where 100 = extremely palatable.
  • At screening, participants must rate the selected low-palatability foods between 10 and 40 on a 100-unit visual analog scale.

Who cannot join

  • Younger than 18 years or older than 60 years.
  • Current medication use.
  • Allergies or food sensitivities to any study foods.
  • Not meeting the required palatability rating ranges during screening.
  • Anticipated change in physical activity during the study period.
  • Not self-reporting good health.
  • Unwillingness or inability to complete the planned study activities.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Purdue University

    West Lafayette, Indiana, 47907

Other trials in United States

About this study

Official title: Ultra-Processed Foods - Palatability and Appetite

The goal of this clinical trial is to learn how food processing level affects appetite and gastrointestinal transit time when meal palatability is changed. Participants will complete one screening visit and four test visits. During each test visit, participants will consume one of four meals that differ by food processing level and palatability: high-palatability ultra-processed food, low-palatability ultra-processed food, high-palatability non-ultra-processed food, or low-palatability non-ultra-processed food. The main questions this study aims to answer are whether food processing and palatability affect appetite sensations and gastrointestinal transit time. Participants will rate appetite sensations during each test visit and provide breath samples to measure gastrointestinal transit time.

Read the detailed description

This is a randomized crossover trial examining the effects of food processing level and palatability on appetite and gastrointestinal transit time. Participants will complete a screening visit followed by four test visits, with each test visit separated by at least one week. Each participant will consume all four test meals: high-palatability ultra-processed food, low-palatability ultra-processed food, high-palatability non-ultra-processed food, and low-palatability non-ultra-processed food. Palatability will be reduced by adding bitter melon powder to the low-palatability meals. During each test visit, participants will consume the assigned test meal containing lactulose as a marker of gastrointestinal transit time. Breath samples will be collected to assess orocecal transit time using hydrogen analysis. Participants will also rate meal palatability and appetite sensations, including hunger, fullness, desire to eat, amount they could eat, and thirst, using visual analog scales during the test visit.

Being tested
Palatable Ultra-Processed Food Meal, Unpalatable Ultra-Processed Food Meal, Palatable Non-Ultra-Processed Food Meal, Unpalatable Non-Ultra-Processed Food Meal
Keywords
Ultra-processed foods, Non-ultra-processed foods, Palatability, Appetite, Gastrointestinal transit time, Orocecal transit time, Hydrogen breath test, Lactulose, Visual analog scale, Bitter melon powder
Medical subject headings
Feeding Behavior

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Palatable Ultra-Processed Food MealOther

    Participants will consume a palatable ultra-processed test meal during one study visit. The meal will consist of commonly available ultra-processed food items and will be used to assess appetite sensations, meal palatability, and gastrointestinal transit time.

  • Unpalatable Ultra-Processed Food MealOther

    Participants will consume an unpalatable ultra-processed test meal during one study visit. Palatability will be reduced by adding organic bitter melon powder to the ultra-processed meal. The meal will be used to assess appetite sensations, meal palatability, and gastrointestinal transit time.

  • Palatable Non-Ultra-Processed Food MealOther

    Participants will consume a palatable non-ultra-processed test meal during one study visit. The meal will consist of commonly available non-ultra-processed food items and will be used to assess appetite sensations, meal palatability, and gastrointestinal transit time.

  • Unpalatable Non-Ultra-Processed Food MealOther

    Participants will consume an unpalatable non-ultra-processed test meal during one study visit. Palatability will be reduced by adding organic bitter melon powder to the non-ultra-processed meal. The meal will be used to assess appetite sensations, meal palatability, and gastrointestinal transit time.

Study groups in NCT07600281
Study groupRoleWhat they receive
Palatable Ultra-Processed FoodExperimentalParticipants will consume a palatable ultra-processed test meal during one study visit. The meal will be used to assess appetite sensations, palatability ratings, and gastrointestinal transit time.
Receives: Other: Palatable Ultra-Processed Food Meal
Unpalatable Ultra-Processed FoodExperimentalParticipants will consume an unpalatable ultra-processed test meal during one study visit. Palatability will be reduced by adding bitter melon powder. The meal will be used to assess appetite sensations, palatability ratings, and gastrointestinal transit time.
Receives: Other: Unpalatable Ultra-Processed Food Meal
Palatable Non-Ultra-Processed FoodExperimentalParticipants will consume a palatable non-ultra-processed test meal during one study visit. The meal will be used to assess appetite sensations, palatability ratings, and gastrointestinal transit time.
Receives: Other: Palatable Non-Ultra-Processed Food Meal
Unpalatable Non-Ultra-Processed FoodExperimentalParticipants will consume a unpalatable non-ultra-processed test meal during one study visit. Palatability will be reduced by adding bitter melon powder. The meal will be used to assess appetite sensations, palatability ratings, and gastrointestinal transit time.
Receives: Other: Unpalatable Non-Ultra-Processed Food Meal

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Orocecal Transit Time

    Orocecal transit time will be assessed using hydrogen analysis of end-alveolar breath samples collected after consumption of each test meal. Each test meal will contain lactulose as a marker of gastrointestinal transit time.

    Measured: During each test visit, up to 4.5 hours after meal consumption

  2. Appetite Sensations

    Appetite sensations, including hunger, fullness, desire to eat, prospective food consumption, and thirst, will be assessed using 100-mm visual analog scales during each test visit after consumption of the assigned test meal every 30 minutes. Each visual analog scale ranges from 0 to 100 mm, with higher scores indicating a greater intensity of the rated sensation. Higher scores are not inherently better or worse outcomes, but reflect greater hunger, fullness, desire to eat, prospective food consumption, or thirst, depending on the item.

    Measured: During each test visit, up to 4.5 hours after meal consumption

  3. Meal Palatability Ratings

    Meal palatability will be assessed using a 100-mm general labeled magnitude scale during each study visit. The scale ranges from 0 to 100 mm, with 0 mm anchored by "most disliked sensation imaginable," 50 mm anchored by "neutral," and 100 mm anchored by "most liked sensation imaginable." Higher scores indicate greater liking of the test meal and therefore a more favorable palatability rating.

    Measured: During each test visit, up to 4.5 hours after meal consumption

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 May 2026
  2. Study start24 Sep 2024
  3. Primary completion30 Apr 2026
  4. Study completion30 Apr 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Crossover
Model description
This is a within-subject crossover trial. Each participant will complete four test visits and consume each of the four test meals: high-palatability ultra-processed food, low-palatability ultra-processed food, high-palatability non-ultra-processed food, and low-palatability non-ultra-processed food. Test visits will be separated by at least one week.
Masking
None (open label)
Enrolment
40 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07600281
Sponsor's protocol ID
IRB-2024-450
Status last verified
May 2026
First submitted
14 May 2026
Last updated
22 May 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data will not be shared because the current IRB-approved protocol does not include a formal plan for external individual participant data sharing. Study data will be de-identified for analysis, and identifying information will be stored separately from study data. Code numbers linking participants to their data will be destroyed according to the approved protocol. No information by which participants can be identified will be released or published.

Publications

  • Hall KD, Ayuketah A, Brychta R, Cai H, Cassimatis T, Chen KY, Chung ST, Costa E, Courville A, Darcey V, Fletcher LA, Forde CG, Gharib AM, Guo J, Howard R, Joseph PV, McGehee S, Ouwerkerk R, Raisinger K, Rozga I, Stagliano M, Walter M, Walter PJ, Yang S, Zhou M. Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake. Cell Metab. 2019 Jul 2;30(1):67-77.e3. doi: 10.1016/j.cmet.2019.05.008. Epub 2019 May 16.

    PubMed 31105044

Questions about this trial

What is this clinical trial studying?

A study testing Palatable Ultra-Processed Food Meal, Unpalatable Ultra-Processed Food Meal and Palatable Non-Ultra-Processed Food Meal in people with Appetite and Gastrointestinal Transit, run by Purdue University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 22 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Orocecal Transit Time (time frame: During each test visit, up to 4.5 hours after meal consumption). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07600281, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 May 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in